Sub-Total: $0.00
Mechanistic Safety Screening for Nutraceutical Ingredient Development
The nutraceutical and dietary supplement market continues to expand as consumers seek products supporting areas such as metabolic health, healthy aging, immune function, energy, and cognitive performance. At the same time, ingredient innovation is moving beyond traditional vitamins and minerals toward botanical extracts, purified natural products, fermentation-derived ingredients, and other biologically active compounds.
That innovation creates an important safety challenge. An ingredient may be selected because it influences a desirable biological process, but biologically active compounds rarely interact with only one molecular target. Understanding unintended activity earlier in development can help companies make better decisions before investing in formulation, manufacturing, and commercialization.
Cell-based receptor assays that measure functional activity across biologically relevant receptor systems can provide an additional layer of mechanistic information for evaluating new ingredients. For ingredient developers, supplement brands, and safety teams, early mechanistic safety screening can help identify functional activity before major investments in formulation, manufacturing, or commercialization.
The Rise of Supplements Increases the Need for Mechanistic Safety Data
Traditional toxicology testing remains an important part of ingredient safety assessment. However, conventional endpoints do not always reveal how an ingredient interacts with human receptor systems or other functional biological targets.
This distinction matters as nutraceutical products become more sophisticated. Botanical extracts, for example, may contain dozens or hundreds of chemical constituents. Purified natural compounds may demonstrate potent biological activity even when their intended nutritional or physiological benefits are well characterized.
Mechanistic testing can help developers answer questions such as:
- Does the ingredient activate or inhibit hormone-related receptors?
- Could it influence xenobiotic metabolism?
- Does it interact with receptor systems involved in metabolic regulation?
- Does activity appear only at high concentrations, or is it detectable within a more relevant exposure range?
These data do not independently establish whether an ingredient is safe or unsafe. Instead, they help identify biological activity that may warrant additional investigation and provide context for broader toxicological evaluations.
Common Off-Target Receptors in Nutraceutical Development
Several receptors can be particularly useful when evaluating biologically active food and supplement ingredients.
Estrogen and androgen receptors may be relevant for botanical ingredients containing compounds with hormone-like structures or activity. Detecting estrogenic, anti-estrogenic, androgenic, or anti-androgenic effects can help developers identify potential endocrine activity early.
Pregnane X receptor (PXR) is an important regulator of enzymes and transporters involved in xenobiotic metabolism. Activation of PXR may indicate that an ingredient has the potential to influence metabolic processes associated with drug disposition, making it a useful receptor target when investigating possible supplement-drug interactions.
Aryl hydrocarbon receptor (AhR) responds to a diverse range of naturally occurring and environmental compounds. Because AhR participates in xenobiotic responses as well as other physiological processes, unexpected activation can provide useful mechanistic information during ingredient characterization.
Peroxisome proliferator-activated receptors (PPARs) regulate processes including lipid and glucose metabolism. Activity at these receptors may sometimes align with the intended purpose of a metabolic-health ingredient, but unintended or unusually strong activity can still be important to characterize.
The appropriate receptor panel should depend on the ingredient, intended use, available literature, chemical composition, and existing safety questions rather than applying the same targets to every product.
Using Bioassays to Evaluate Nutraceutical Ingredients
Cell-based luciferase reporter assays provide a practical method for examining functional activity across these receptor systems.
Rather than determining only whether a compound physically binds to a receptor, reporter assays measure whether that interaction produces a functional cellular response. An engineered cell responds to activation or inhibition of the target receptor by generating a measurable signal, allowing researchers to characterize agonist or antagonist activity.
A typical screening strategy can begin with testing an ingredient or compound across selected receptor targets. If activity is identified, concentration-response testing can provide additional information about potency, efficacy, and whether the response changes predictably with increasing concentration.
This approach can help ingredient developers distinguish meaningful, reproducible activity from isolated screening signals. Results can then help teams compare candidate ingredients, evaluate different extracts or formulations, prioritize follow-up toxicology studies, and identify receptor activity that may need additional investigation before commercialization.
Bioassays can also be valuable when comparing ingredient sources. Two botanical extracts carrying the same product name, for example, may differ substantially in composition because of cultivar, extraction process, growing conditions, or manufacturing methods. Functional testing provides another way to evaluate whether those differences also translate into different biological activity.
How Nutraceutical Safety Assays Fit into Regulatory Considerations
Mechanistic bioassays should be viewed as one component of a broader safety strategy rather than as a regulatory safety determination by themselves.
In the United States, manufacturers and distributors remain responsible for evaluating the safety of the dietary ingredients they market. For certain new dietary ingredients, FDA requires a New Dietary Ingredient Notification containing the basis for concluding that the ingredient is reasonably expected to be safe under its recommended conditions of use.
When an NDI notification is required, it generally must be submitted at least 75 days before the ingredient or supplement is introduced into interstate commerce. FDA also emphasizes the importance of supporting the safety conclusion with appropriate scientific evidence.
Cell-based receptor assays can complement literature reviews, analytical characterization, conventional toxicology studies, exposure assessments, and other evidence used during ingredient development. Their particular value is in identifying functional biological activity that may otherwise remain unclear until later-stage testing.
For nutraceutical companies developing increasingly bioactive ingredients, incorporating mechanistic screening earlier can support more informed candidate selection and help identify questions while they are still practical to investigate. Cell-based receptor assays are not a substitute for comprehensive safety assessment, but they can provide valuable evidence about how an ingredient interacts with human biology and where developers may need to look more closely.
INDIGO Biosciences offers cell-based receptor assay kits and services that can help nutraceutical and dietary ingredient developers evaluate functional activity across selected human receptor targets, including endocrine, xenobiotic-sensing, and metabolic receptor systems. These assays can support earlier identification of off-target activity, comparison of ingredient sources or formulations, and more informed follow-up safety planning.
Explore INDIGO’s cell-based receptor assay kits and services to support mechanistic safety screening for nutraceutical and dietary ingredient development.
References:
U.S. Food and Drug Administration. (2023). New dietary ingredients in dietary supplements: Background for industry. https://www.fda.gov/food/new-dietary-ingredient-ndi-notification-process/new-dietary-ingredients-dietary-supplements-background-industry